Orgenesis Rg

Orgenesis Inc. delivers closed‑loop, automated point‑of‑care platforms for autologous cell and gene‑based therapies, targeting immunotherapy, metabolic, antiviral, and regenerative markets, leveraging a global network of research institutes and hospitals to accelerate adoption.

Headquarters: United States (USA)